Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1957 1
1959 1
1963 2
1964 4
1965 2
1966 2
1967 4
1968 3
1969 7
1970 3
1971 3
1972 3
1973 8
1974 5
1975 10
1977 12
1978 5
1979 2
1980 6
1981 9
1982 4
1983 6
1984 3
1985 6
1986 14
1987 5
1988 3
1989 4
1990 15
1991 7
1992 9
1993 12
1994 6
1995 2
1996 8
1997 7
1998 12
1999 11
2000 10
2001 17
2002 15
2003 18
2004 30
2005 28
2006 41
2007 44
2008 50
2009 44
2010 52
2011 52
2012 35
2013 45
2014 46
2015 54
2016 42
2017 48
2018 56
2019 59
2020 73
2021 68
2022 71
2023 44
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,123 results

Results by year

Filters applied: . Clear all
Page 1
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, Gomi F, Koh AH, Kokame G, Jordan-Yu JM, Corvi F, Invernizzi A, Ogura Y, Tan C, Mitchell P, Gupta V, Chhablani J, Chakravarthy U, Sadda SR, Wong TY, Staurenghi G, Lee WK. Cheung CMG, et al. Ophthalmology. 2021 Mar;128(3):443-452. doi: 10.1016/j.ophtha.2020.08.006. Epub 2020 Aug 11. Ophthalmology. 2021. PMID: 32795496 Free article.
Evolving treatment paradigms for PCV.
Fenner BJ, Cheung CMG, Sim SS, Lee WK, Staurenghi G, Lai TYY, Ruamviboonsuk P, Kokame G, Yanagi Y, Teo KYC. Fenner BJ, et al. Eye (Lond). 2022 Feb;36(2):257-265. doi: 10.1038/s41433-021-01688-7. Epub 2021 Jul 14. Eye (Lond). 2022. PMID: 34262165 Free PMC article. Review.
Current clinical trial data suggest intravitreal anti-vascular endothelial growth factor (VEGF) therapy alone or in combination with photodynamic therapy is effective in managing haemorrhage and exudation in PCV, although the optimal treatment interval, including as …
Current clinical trial data suggest intravitreal anti-vascular endothelial growth factor (VEGF) therapy alone or in combination with …
Surgical Management of Choroidal Diseases.
Hattenbach LO, Bopp S, Strobel M, Chronopoulos A. Hattenbach LO, et al. Klin Monbl Augenheilkd. 2021 Sep;238(9):980-987. doi: 10.1055/a-1554-5496. Epub 2021 Aug 20. Klin Monbl Augenheilkd. 2021. PMID: 34416789 Review. English, German.
In addition to prognostic factors, timely recognition and prompt, if possible preventive, acute care, as well as carefully considered timing of adequate surgical measures taking advantage of the specific characteristics of the choroidal tissue, are crucial to treatment suc …
In addition to prognostic factors, timely recognition and prompt, if possible preventive, acute care, as well as carefully considered …
Risk factors and management of choroidal effusions.
Ying S, Sidoti PA, Panarelli JF. Ying S, et al. Curr Opin Ophthalmol. 2023 Mar 1;34(2):162-167. doi: 10.1097/ICU.0000000000000929. Epub 2022 Nov 9. Curr Opin Ophthalmol. 2023. PMID: 36730733 Review.
Although choroidal effusions typically resolve with medical therapy alone, surgical intervention may be required. Various methods of surgical intervention, such as surgical drainage or GDD tube ligation, can be utilized to treat choroidal effusions when conservative manage …
Although choroidal effusions typically resolve with medical therapy alone, surgical intervention may be required. Various methods of …
Update on the diagnosis and treatment of choroidal hemangioma.
García Caride S, Fernández-Vigo JI, Valverde-Megías A. García Caride S, et al. Arch Soc Esp Oftalmol (Engl Ed). 2023 May;98(5):281-291. doi: 10.1016/j.oftale.2023.04.006. Epub 2023 Apr 14. Arch Soc Esp Oftalmol (Engl Ed). 2023. PMID: 37062411 Review.
Choroidal hemangioma (CH) is a benign vascular tumor dependent on the choroid. Two types of lesions are distinguished: circumscribed (CCH), the most frequent variant, and diffuse (DCH), normally associated with Sturge-Weber syndrome. ...This has been due to the use of phot …
Choroidal hemangioma (CH) is a benign vascular tumor dependent on the choroid. Two types of lesions are distinguished: circumscribed …
Clinical features and therapeutic management of choroidal osteoma: A systematic review.
Zhang L, Ran QB, Lei CY, Zhang MX. Zhang L, et al. Surv Ophthalmol. 2023 Nov-Dec;68(6):1084-1092. doi: 10.1016/j.survophthal.2023.06.002. Epub 2023 Jun 14. Surv Ophthalmol. 2023. PMID: 37321477 Review.
Choroidal osteoma is a benign ossifying tumor within the choroid. Complications associated with choroidal osteoma, including disruption of retinal pigment epithelium, atrophy of photoreceptors, subretinal fluid, and choroidal neovascularization, present challenges for clin …
Choroidal osteoma is a benign ossifying tumor within the choroid. Complications associated with choroidal osteoma, including disrupti …
Diagnosis and Treatment of Myopic Maculopathy.
Yokoi T, Ohno-Matsui K. Yokoi T, et al. Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):415-421. doi: 10.22608/APO.2018290. Epub 2018 Sep 26. Asia Pac J Ophthalmol (Phila). 2018. PMID: 30255668 Free article. Review.
Recent large clinical trials have reported a good initial efficacy for visual acuity improvement by application of anti-vascular endothelial growth factor therapy for myopic CNVs. However, long-term clinical studies demonstrate a gradual decrease in the visual acuity gain …
Recent large clinical trials have reported a good initial efficacy for visual acuity improvement by application of anti-vascular endothelial …
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
METHODS: 192 Study Group members from 48 countries completed a 36-item survey on clinical features, use of investigations, indications for treatment, systemic and intravitreal treatment with antiparasitic drugs and corticosteroids, and approach to follow-up and preventive ther …
METHODS: 192 Study Group members from 48 countries completed a 36-item survey on clinical features, use of investigations, indications for t …
MYOPIC CHOROIDAL NEOVASCULARIZATION: Diagnosis and Treatment.
Lai TY, Cheung CM. Lai TY, et al. Retina. 2016 Sep;36(9):1614-21. doi: 10.1097/IAE.0000000000001227. Retina. 2016. PMID: 27482641 Review.
The current first line treatment of mCNV is the use of anti-vascular endothelial growth factor therapy. CONCLUSION: Various investigations can assist the differentiation of mCNV from other coexisting retinal pathologies associated with myopia or choroidal neovascularizatio …
The current first line treatment of mCNV is the use of anti-vascular endothelial growth factor therapy. CONCLUSION: Various investiga …
Diagnosis and Treatment of Primary Inflammatory Choriocapillaropathies (PICCPs): A Comprehensive Overview.
Papasavvas I, Herbort CP Jr. Papasavvas I, et al. Medicina (Kaunas). 2022 Jan 21;58(2):165. doi: 10.3390/medicina58020165. Medicina (Kaunas). 2022. PMID: 35208488 Free PMC article. Review.
PURPOSE: Primary inflammatory choriocapillaropathies (PICCPs) belong to a group of intraocular inflammatory diseases with the common characteristic of inflammatory choriocapillaris hypo- or non-perfusion as the main clinicopathological mechanism. ...ICGA findings are essen …
PURPOSE: Primary inflammatory choriocapillaropathies (PICCPs) belong to a group of intraocular inflammatory diseases with the common …
1,123 results